Trial Information
Current as of May 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: - patients with a three- or four-fragment-fracture of the proximal humerus, with dislocation on X-ray
- • older than 60 years of age
- • written and signed patient consent
- • Exclusion Criteria: - Fractures more than 14 days old
- • multiple comorbidity
- • multitrauma (Injury Severity Score \> 15)
- • prev. surgery on the injured shoulder
- • severely deranged function caused by a previous disease head-split proximal humerus fracture
- • combined humerus head and shaft fractures
- • pseudarthroses
- • crushed head cap of the humerus head (AO 11 C3 fractures)
- • isolated avulsion fracture of a tuberosity
- • unwillingness or inability to follow protocol instructions and study requirements (follow-up visits)
- • no signed informed consent
- • treatment not in line with Instructions for Use (IfU)
About Aesculap Ag
Aesculap AG is a prominent global medical device manufacturer specializing in surgical instruments, implants, and innovative healthcare solutions. With a rich history rooted in excellence and innovation, Aesculap AG is dedicated to advancing surgical practices through cutting-edge technology and a commitment to improving patient outcomes. The company collaborates with healthcare professionals and institutions to conduct clinical trials that evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of quality and performance. Through its rigorous research and development initiatives, Aesculap AG aims to contribute significantly to the field of medicine and enhance the standards of surgical care worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nürnberg, Bayern, Germany
Patients applied
Trial Officials
Hermann Josef Bail, Prof. Dr.
Principal Investigator
Klinikum Nürnberg Süd
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials